Thursday, July 31, 2025

2 Reasons to Avoid Amazon Stock as Tariffs Escalate

How does this make you feel?


Despite President Trump’s suspension of most tariffs, those on Chinese goods remain high and are expected to rise, impacting companies like Amazon (AMZN). With approximately 62% of Amazon’s items sold through third-party sellers, many of whom source from China, the tariffs could force price increases or seller exits, reducing product variety and revenue. Additionally, a slowdown in IT spending may adversely affect Amazon Web Services (AWS), making Amazon stock a risky investment amidst potential economic downturns.

Full Article

Related Posts

Why Did Micron Stock Drop Today?

Shares of Micron Technology (NASDAQ: MU) fell 5.2% on Thursday morning, primarily due to issues attributed to Samsung, rather than any specific actions by Micron itself. The decline highlights the interconnected nature of the semiconductor industry and how external factors can significantly impact stock performance. Want More Context? 🔎

Read more

Lenz (LENZ) Q2 Revenue Jumps 604%

Lenz Therapeutics (NASDAQ:LENZ) reported second quarter 2025 results on July 30, revealing $5.0 million in GAAP revenue from licensing milestones, significantly surpassing analyst expectations. Despite a deeper net loss due to increased spending, the company made strides in its commercial plans ahead of an important FDA decision for its lead product, LNZ100, aimed at treating presbyopia. Want More Context? 🔎

Read more

Are XRP and Bitcoin's Dips Simply Normal Corrections or Signs of a Cooling Crypto Market?

Bitcoin (CRYPTO: BTC) and XRP (CRYPTO: XRP) have experienced significant pullbacks after a period of strong growth, with XRP dropping nearly 20% in one session and Bitcoin retreating after hitting a record high in July. Despite concerns that the summer rally might be over, these pullbacks are considered typical in a bull market, suggesting they are just temporary pauses rather than a sign of a trend reversal. Want More Context? 🔎

Read more

Wave (WVE) Q2 Revenue Drops 56%

Wave Life Sciences (NASDAQ:WVE) reported disappointing Q2 2025 earnings, with revenue of $8.7 million falling short of the $13.2 million forecast and a loss per share of $0.31 versus the anticipated $0.28. Despite a 55.8% year-over-year revenue decline and increased operating expenses, the company made progress in its RNA-based medicine pipeline using its proprietary PRISM platform. Want More Context? 🔎

Read more

Blackbaud (BLKB) Q2 EPS Jumps 12%

Blackbaud (NASDAQ:BLKB), a provider of cloud software for social impact organizations, reported strong Q2 2025 results with non-GAAP earnings per share of $1.21, surpassing expectations, and a 6.8% organic revenue growth to $281.4 million, despite a 2.1% year-over-year decline in reported revenue due to the sale of EVERFI. Management has raised its full-year guidance following record profitability metrics for the quarter. Want More Context? 🔎

Read more

Home Federal (HFBL) Q2 EPS Jumps 81%

Home Federal Bancorp of Louisiana (NASDAQ:HFBL) reported a net income of $1.2 million for the quarter ending June 30, 2025, significantly up from $638,000 the previous year, with diluted earnings per share rising to $0.38. The bank, serving northwest Louisiana, attributes these gains to lower funding costs and increased non-interest income, although it faces challenges with asset quality and deposit contraction. Want More Context? 🔎

Read more

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.